134 related articles for article (PubMed ID: 3923987)
1. [Treatment of supraventricular and paroxysmal ventricular tachycardia with bepridil].
Fauchier JP; Cosnay P; Néel C; Rouesnel P; Bonnet P; Quilliet L
Arch Mal Coeur Vaiss; 1985 Apr; 78(4):612-9. PubMed ID: 3923987
[TBL] [Abstract][Full Text] [Related]
2. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
Fauchier JP; Rouesnel P; Breuillac JC; Cosnay P; Scheck F; Garnier LF
Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):194-203. PubMed ID: 8024234
[TBL] [Abstract][Full Text] [Related]
3. [Bepridil in the treatment of supraventricular paroxysmal tachycardias].
Medvedowsky JL; Barnay C; Arnaud C; Bonet P; Quittet F; Lam LF
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():67-74. PubMed ID: 3938262
[TBL] [Abstract][Full Text] [Related]
4. [Injectable and oral propafenone in nodal reentry and pathways of ventricular preexcitation].
Fauchier JP; Cosnay P; Moquet B; Rouesnel P; Kapusta P; Vrancea F
Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1506-14. PubMed ID: 3099684
[TBL] [Abstract][Full Text] [Related]
5. [Oral and intravenous bepridil in the treatment of recurrent sustained ventricular tachycardias. Electropharmacological study].
Lévy S; Metge M; Cointe R; Labrunie P; Valeix P; Gérard R
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():63-6. PubMed ID: 3938261
[TBL] [Abstract][Full Text] [Related]
6. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Bonnet P; Scala PJ; Demeyer JF
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
[TBL] [Abstract][Full Text] [Related]
7. Accessory pathway reciprocating tachycardia.
Obel OA; Camm AJ
Eur Heart J; 1998 May; 19 Suppl E():E13-24, E50-1. PubMed ID: 9717020
[TBL] [Abstract][Full Text] [Related]
8. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
[TBL] [Abstract][Full Text] [Related]
9. [Anti-arrhythmia and electrophysiological effects of encainide in supraventricular tachycardias].
Cassagneau B; Miquel JP; Puel JP; Mordant B; Kher A; Fauvel JM; Bounhoure JP
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():113-9. PubMed ID: 3938253
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of oral bepridil in ventricular arrhythmias in stable coronary insufficiency].
Rio A; Pasco A; Dupont T; Deroubaix G; Moulinie E; Rossignol B; Pellet J; Brechenmacher C
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():75-8. PubMed ID: 3938263
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
Gambhir DS; Bhargava M; Arora R; Khalilullah M
Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
[TBL] [Abstract][Full Text] [Related]
12. [Retrograde ventriculo-auricular heart conduction in 126 patients with or without supra-ventricular paroxysmal tachydardia, with or without ventricular preexcitation].
Fauchier JP; Latour F; Charbonnier B; Neel C; Brochier M
Arch Mal Coeur Vaiss; 1980 Apr; 73(4):349-60. PubMed ID: 6778436
[TBL] [Abstract][Full Text] [Related]
13. [Anti-arrhythmic effects of intravenous magnesium sulfate in paroxysmal supraventricular tachycardia].
Etienne Y; Blanc JJ; Boschat J; Le Potier J; Jobic Y; Le Grand O; Penther P
Ann Cardiol Angeiol (Paris); 1988 Nov; 37(9):535-8. PubMed ID: 3223727
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic treatment of atrioventricular tachycardias.
Goy JJ; Fromer M
J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S36-40. PubMed ID: 1723116
[TBL] [Abstract][Full Text] [Related]
15. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
Kim SS; Lal R; Ruffy R
Am J Cardiol; 1986 Jul; 58(1):80-5. PubMed ID: 3728336
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia].
Brandão L; de Sousa J; Barreiros MC; Vagueiro MC; Amram SS
Rev Port Cardiol; 1994 Mar; 13(3):197-202, 191. PubMed ID: 8049086
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic effects and long-term efficacy of bepridil for recurrent supraventricular tachycardias.
Roy D; Montigny M; Klein GJ; Sharma AD; Cassidy D
Am J Cardiol; 1987 Jan; 59(1):89-92. PubMed ID: 3492906
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic and antiarrhythmic properties of bepridil.
Prystowsky EN
Am J Cardiol; 1985 Mar; 55(7):59C-62C. PubMed ID: 3872056
[TBL] [Abstract][Full Text] [Related]
19. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF
Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
